Integra LifeSciences Holdings Corporation (FRA:IL3)

Market Cap	827.46M -20.2%
Revenue (ttm)	1.46B +0.8%
Net Income	11.46M
EPS	0.15
Shares Out	n/a
PE Ratio	72.81
Forward PE	5.12
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Open	10.90
Previous Close	10.30
Day's Range	10.90 - 10.90
52-Week Range	7.60 - 17.30
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 21, 2026

About FRA:IL3

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1989
• Employees: 4,427
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: IL3

Financial Performance

In 2025, FRA:IL3's revenue was $1.64 billion, an increase of 1.53% compared to the previous year's $1.61 billion. Losses were -$516.47 million, 7337.7% more than in 2024.

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error